Divi’s Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company operates globally, with facilities in India, the United States, and Europe, and serves customers in over 60 countries. Divi’s Laboratories is known for its strong focus on quality and innovation, and has a […]
Divi’s Laboratories Ltd (NSE:DIVISLAB) Q1 FY23 Earnings Concall dated Aug. 12, 2022 Corporate Participants: Satish Choudhury — Company Secretary and Chief Investor Relations Officer Murali K. Divi — Managing Director Nilima Divi — Whole-Time Director, Commercial Analysts: Tushar Manudhane — Motilal Oswal Financial Services — Analyst Surya Narayan Patra — PhillipCapital India Private Limited — […]
Divi’s Laboratories Ltd (NSE:DIVISLAB) Q2 FY22 Earnings Concall dated Nov. 06, 2021. Corporate Participants: M. Satish Choudhury — Company Secretary & Compliance Officer Murali K. Divi — Managing Director Nilima Prasad Divi — Whole-Time Director (Commercial) Analysts: Tushar Manudhane — Motilal Oswal Financial Services — Analyst Shyam Srinivasan — Goldman Sachs — Analyst Prakash Agarwal — […]